Dr. Groysman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1625 N Campbell Ave
Tucson, AZ 85719Phone+1 520-694-8888Fax+1 520-694-1014
Education & Training
University of Arizona College of Medicine - PhoenixClass of 2020
Publications & Presentations
PubMed
- 14 citationsOncogene Overdose: Too Much of a Bad Thing for Oncogene-Addicted Cancer Cells.Amit Dipak Amin, Soumya Sundara Rajan, Matthew Groysman, Praechompoo Pongtornpipat, Jonathan H. Schatz
Biomarkers in Cancer. 2015-12-15 - 29 citationsEvidence Suggesting that Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ TumorsAmit Dipak Amin, Soumya Sundara Rajan, Winnie S. Liang, Praechompoo Pongtornpipat, Matthew Groysman
Cancer Research. 2015-07-15 - 15 citationsTKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumorsAmit Dipak Amin, Lingxiao Li, Soumya Sundara Rajan, Vijay Gokhale, Matthew Groysman
Oncotarget. 2016-03-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
